Gina Guzman, M.D., Promoted to Vice President and Chief Medical Director at Munich Re US (Life)

Normal view (turn off text only mode)
You are here:

8 February 2016

Munich Re Publishes New Publication on Underwriting Considerations for Pre-Exposure Prophylaxis Against Human Immunodeficiency Virus (HIV)

Atlanta, GA – Munich Re, U.S. (Life) is pleased to announce the publication of, “Underwriting Considerations for Pre-Exposure Prophylaxis Against HIV Infection with Truvada®”. The release of the paper follows the December 2015 announcement of Munich Re partnering with Prudential Financial on the innovative initiative to make life insurance coverage available to people in the United States who are living with HIV.

“We’re constantly monitoring medical advancements from around the world to help our customers expand their customer base,” stated Bill Moore, vice president, underwriting and medical for Munich Re, U.S. (Life).  “We’re particularly proud of our efforts in this area, because we hope it not only helps our customers take a focused, proactive approach to providing innovative coverage, but that it also benefits individuals living with, or otherwise affected by HIV, who have been largely underserved by the U.S. life insurance industry until now.” 

 “Underwriting Considerations for Pre-Exposure Prophylaxis Against HIV Infection with Truvada®” covers the CDC’s Pre-Exposure Prophylaxis (PrEP) guidelines and protocol for use of the anti-retroviral medication, Truvada. Truvada has been championed since 2012 by the Centers for Disease Control (CDC) as a way to help prevent HIV infections for populations at high risk for acquisition of the virus from sexual activity. The paper also includes potentially relevant commentary for Life and Disability Insurers to consider when developing underwriting guidelines. “Underwriting Considerations for Pre-Exposure Prophylaxis Against HIV Infection with Truvada®” is available both online in Munich Re’s, U.S. Life Publications and in the reference documents of Munich Re’s Web-based underwriting manual, EDGE.

For an overview of underwriting considerations for HIV(+) applicants, please refer to the HIV reference materials in EDGE, or contact your Munich Re representative for more information. To inquire about accessing the EDGE Underwriting Manual, please send an email to

Note for the editorial staff:
For further questions please contact

Media Relations, Munich American Reassurance Company
Meaghan Kenagy
Tel.: 770-350-3222
Munich American Reassurance Company, (Munich Re US (Life)) founded in 1959, is one of the largest reinsurers in the U.S. offering life and disability reinsurance to insurance companies throughout the United States. The company also writes group, credit and other reinsurance products. Headquartered in Atlanta, with an office in Chicago, the company is licensed, accredited or authorized in all fifty states; Washington, D.C.; Guam; and Puerto Rico.

Munich Re stands for exceptional solution-based expertise, consistent risk management, financial stability and client proximity. This is how Munich Re creates value for clients, shareholders and staff. In the financial year 2014, the Group – which combines primary insurance and reinsurance under one roof – achieved a profit of €3.2bn on premium income of over €48bn. It operates in all lines of insurance, with over 43,000 employees throughout the world. With premium income of around €27bn from reinsurance alone, it is one of the world’s leading reinsurers. Especially when clients require solutions for complex risks, Munich Re is a much sought-after risk carrier. Its primary insurance operations are concentrated mainly in the ERGO Insurance Group, one of the leading insurance groups in Germany and Europe. ERGO is represented in over 30 countries worldwide and offers a comprehensive range of insurances, provision products and services. In 2014, ERGO posted premium income of €18bn. In international healthcare business, Munich Re pools its insurance and reinsurance operations, as well as related services, under the Munich Health brand. Munich Re’s global investments amounting to €227bn are managed by MEAG, which also makes its competence available to private and institutional investors outside the Group.

This press release contains forward-looking statements that are based on current assumptions and forecasts of the management of Munich Re. Known and unknown risks, uncertainties and other factors could lead to material differences between the forward-looking statements given here and the actual development, in particular the results, financial situation and performance of our Company. The Company assumes no liability to update these forward-looking statements or to conform them to future events or developments.


Main Navigation
Service Men

© Copyright 2015 Munich American Reassurance Company. All Rights Reserved.


This publication is available exclusively to Munich Re clients. Please contact your Client Manager.